The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
Timestops (2)
Tools Used
Topic Overview
Key Takeaways
- Prenatal diagnosis advances enable early detection of genetic conditions, opening a window for in utero intervention.
- Fetal immune tolerance and permeable blood-brain barrier create unique therapeutic advantages not present after birth.
- Maternal administration of enzyme replacement or protein therapy can cross the placenta to treat the fetus directly.
- Stem cell therapy during fetal development may prevent irreversible organ damage before disease manifestation.
- Most fetal gene therapies remain experimental but hold promise for preventing lifelong morbidity from genetic diseases.
Keywords
Hashtags
Transcript
What if we could treat genetic diseases before a baby is even born? I'm Lizzie Lee from Cincinnati Children's, and this is an article you should know about. This new review highlights a growing frontier in fetal medicine, treating genetic disease in the womb. With faster prenatal diagnosis, doctors can now detect many genetic conditions early. Some approaches are giving medications to the mother that cross the placenta, delivering enzyme replacement therapy. Directly to the fetus and even protein therapy and stem cells. The fetus actually has some advantages for treatment, a more tolerant immune system and a more permissive blood-brain barrier. Most of these treatments are still experimental, but the idea is powerful. Intervene during fetal development to prevent lifelong disease. Let us know what you think and stay tuned for more articles that you should know about.